{"meta":{"query_hash":"2f0cc07a5f23","filters":{"venue":"International Journal of Drug Regulatory Affairs"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2f0cc07a5f23","api":"https://metacan.xera.ac/api/v1/cohort?venue=International+Journal+of+Drug+Regulatory+Affairs"},"results":[{"id":"W2183209710","doi":"10.22270/ijdra.v2i2.130","title":"A PRAGMATIC WAY TO SUSTAIN IN GENERIC PHARMA ENVIRONMENT: PLCM THROUGH REGULATORY STRATEGIES","year":2018,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Profitability index; Business; Quality (philosophy); Product (mathematics); Sustainability; Preference; Marketing; Work (physics); Competitive advantage; Process management; Risk analysis (engineering); Economics; Computer science; Engineering; Finance","score_opus":0.025933142335729867,"score_gpt":0.28150899596129453,"score_spread":0.2555758536255647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183209710","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029876713,0.007480481,0.09999194,0.40020975,0.0012603842,0.0006889541,0.00014622336,0.00052056386,0.459825],"genre_scores_gemma":[0.8590114,0.0046331915,0.046343744,0.057097208,0.00065903424,0.00047555883,0.000082856626,0.00022643936,0.03147049],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9840209,0.008901089,0.00050266477,0.0011725881,0.003685119,0.0017176878],"domain_scores_gemma":[0.98874694,0.0043778927,0.0016300488,0.0013248527,0.0024002066,0.0015200451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01643499,0.0007544459,0.0005729115,0.0017633598,0.0048706452,0.019454014,0.0017247482,0.009294316,0.00906374],"category_scores_gemma":[0.021689238,0.00040773867,0.00088062265,0.0012318733,0.017636672,0.015790384,0.007862046,0.00842435,0.0024376335],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002775842,0.000101308295,0.0007126872,0.00023829544,0.00001980204,0.00034424607,0.0028219048,0.0006815666,0.000933915,0.9465803,0.01482695,0.032711167],"study_design_scores_gemma":[0.00003742417,0.00020421617,0.0010949596,0.0008626889,0.000022773671,0.00034892865,0.0069375345,0.0013347629,0.0016925612,0.6072969,0.3800803,0.000086903274],"about_ca_topic_score_codex":0.002728245,"about_ca_topic_score_gemma":0.0032759258,"teacher_disagreement_score":0.019454014,"about_ca_system_score_codex":0.0075046406,"about_ca_system_score_gemma":0.018641483,"threshold_uncertainty_score":0.08691752},"labels":[],"label_agreement":null},{"id":"W2821537775","doi":"10.22270/ijdra.v6i2.236","title":"Regulatory requirements for Drug master file in context to Canada and Australia","year":2018,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Legislation; Context (archaeology); Terminology; Drug; Business; Quality (philosophy); Product (mathematics); Computer science; Political science; Pharmacology; Medicine; Law; Biology","score_opus":0.05655171049066777,"score_gpt":0.2988763481879289,"score_spread":0.24232463769726115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2821537775","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018629,0.0034788651,0.017806465,0.033221137,0.0034913688,0.009549506,0.032907724,0.007926133,0.8729897],"genre_scores_gemma":[0.109004915,0.004463845,0.044861604,0.041627966,0.0010273568,0.007199219,0.028730322,0.002527746,0.7605571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96225774,0.004248557,0.0029159987,0.002944087,0.023711225,0.003922336],"domain_scores_gemma":[0.8820846,0.01527812,0.003206321,0.00956036,0.08590235,0.0039681727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020809589,0.00055429287,0.00094364304,0.0053799194,0.006524208,0.008290418,0.004654973,0.005993332,0.05861229],"category_scores_gemma":[0.079114355,0.0012645159,0.0011688159,0.0050987513,0.0030957873,0.0036572637,0.0031145227,0.004000229,0.029780397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036452996,0.00020240214,0.0030464432,0.00083884713,0.000023339606,0.0008463169,0.0028172801,0.0006285614,0.00493617,0.084514745,0.8118141,0.08996727],"study_design_scores_gemma":[0.000033648037,0.00004398596,0.008210308,0.0003977778,0.000015397176,0.000272277,0.0003256185,0.00030643685,0.0016182079,0.0010434936,0.9876666,0.00006619272],"about_ca_topic_score_codex":0.5827163,"about_ca_topic_score_gemma":0.52650815,"teacher_disagreement_score":0.4172837,"about_ca_system_score_codex":0.024685804,"about_ca_system_score_gemma":0.097382545,"threshold_uncertainty_score":0.83948237},"labels":[],"label_agreement":null},{"id":"W2883638496","doi":"10.22270/ijdra.v3i4.172","title":"DMF FILING IN US, EUROPE AND CANADA","year":2018,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confidentiality; Drug; Discretion; Business; Product (mathematics); Process (computing); Computer science; Internet privacy; Database; Law; Computer security; Political science; Pharmacology; Medicine; Operating system","score_opus":0.007224715325814822,"score_gpt":0.25728031795722656,"score_spread":0.25005560263141174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883638496","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013162414,0.0028225721,0.0024113238,0.008566,0.0022529846,0.0013244903,0.045776423,0.0016315399,0.9220523],"genre_scores_gemma":[0.0399584,0.0033196441,0.0045677656,0.004596215,0.00025993466,0.00032525999,0.020398922,0.00071636576,0.92585754],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887944,0.0003338634,0.0004624604,0.00074200775,0.007987543,0.001679717],"domain_scores_gemma":[0.9679795,0.0012002039,0.00069074763,0.0011597741,0.027345568,0.0016242348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004213419,0.0007206089,0.00081916095,0.008132717,0.011009203,0.0073915613,0.0024016076,0.0021981061,0.12883002],"category_scores_gemma":[0.02099622,0.00082949235,0.0007980087,0.007924731,0.0016946202,0.0015171388,0.00204917,0.0022648564,0.043439884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008906849,0.00006516732,0.0037791524,0.00022039893,0.0000166833,0.0002858355,0.0007533575,0.00019227146,0.0014684274,0.0313409,0.8997964,0.061992295],"study_design_scores_gemma":[0.000010598277,0.0000105329245,0.011893225,0.00016499788,0.000009492066,0.00006161964,0.00044926893,0.00013078385,0.0010731887,0.00046224167,0.9857062,0.00002797365],"about_ca_topic_score_codex":0.9476745,"about_ca_topic_score_gemma":0.95764107,"teacher_disagreement_score":0.9476745,"about_ca_system_score_codex":0.043780804,"about_ca_system_score_gemma":0.16495903,"threshold_uncertainty_score":0.4309793},"labels":[],"label_agreement":null},{"id":"W2978147562","doi":"10.22270/ijdra.v7i3.341","title":"Regulatory architecture of biosimilars in Singapore: A critical overview","year":2019,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Biological drugs; Product (mathematics); Agency (philosophy); Medicine; Clinical trial; Traditional medicine; Disease","score_opus":0.013321512832161105,"score_gpt":0.29787116975175737,"score_spread":0.28454965691959627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978147562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034267623,0.37762302,0.046364453,0.27059537,0.003007447,0.0020145942,0.0005235825,0.00065436366,0.26494944],"genre_scores_gemma":[0.39148387,0.44150946,0.059082314,0.060780335,0.004342613,0.0014148416,0.0009123134,0.00026112367,0.040213138],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.97960556,0.00832353,0.0024269025,0.0010683337,0.007066075,0.0015096241],"domain_scores_gemma":[0.9797463,0.0066739265,0.004186633,0.0008371933,0.007235247,0.0013208106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034842703,0.0013632462,0.0011022866,0.004886848,0.0020013894,0.01551333,0.0028914225,0.0071301083,0.0056846184],"category_scores_gemma":[0.020019442,0.0010226469,0.0017318999,0.0048746495,0.0049724104,0.012323116,0.004397375,0.006674743,0.0016102447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002035851,0.00032404135,0.0060091903,0.0047925203,0.00013672047,0.0029510085,0.002604759,0.010111365,0.0026914594,0.657222,0.03862617,0.27432713],"study_design_scores_gemma":[0.00006322507,0.0009929048,0.010753644,0.009165304,0.00016107914,0.0026494155,0.002659756,0.006952394,0.0028862485,0.094601706,0.8689114,0.0002028786],"about_ca_topic_score_codex":0.015619921,"about_ca_topic_score_gemma":0.015260863,"teacher_disagreement_score":0.034842703,"about_ca_system_score_codex":0.022537608,"about_ca_system_score_gemma":0.03318352,"threshold_uncertainty_score":0.184268},"labels":[],"label_agreement":null},{"id":"W2978302277","doi":"10.22270/ijdra.v7i3.327","title":"Intellectual Property Right in India- A Review","year":2019,"lang":"en","type":"review","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure","funders":"","keywords":"Business; Intellectual property; Order (exchange); Quality (philosophy); Process (computing); Risk analysis (engineering); Marketing; Computer science; Law; Finance; Political science","score_opus":0.07087529224784708,"score_gpt":0.3310711663333638,"score_spread":0.2601958740855167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978302277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011279241,0.9969573,0.000034662404,0.0005844157,0.00010066274,0.0000027868668,0.0000121144785,0.000002518238,0.0021927129],"genre_scores_gemma":[0.0019674886,0.99729735,0.000041406634,0.0002539632,0.00012547907,0.0000026705195,0.000012166459,0.0000010509024,0.0002984495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994129,0.000111580935,0.0000843791,0.000067238056,0.0002602889,0.00006362275],"domain_scores_gemma":[0.9973181,0.0018220358,0.00033533465,0.00006696416,0.00035915,0.0000983661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012182251,0.00054981105,0.0010307924,0.005146831,0.00057851314,0.0027413617,0.00093518,0.0012329385,0.005473107],"category_scores_gemma":[0.002486635,0.00032467165,0.00062261405,0.007481154,0.0019847278,0.0019947153,0.00088951836,0.0017038016,0.0010110707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005211025,0.000092478986,0.00056473294,0.03990253,0.00013139904,0.00047267668,0.00022802709,0.0006244702,0.0004013589,0.040183917,0.064581774,0.85276455],"study_design_scores_gemma":[0.000010692261,0.00005938454,0.003840055,0.024533743,0.00015243425,0.0016116182,0.00021784489,0.00010931003,0.00026361673,0.006207742,0.96296746,0.000026086786],"about_ca_topic_score_codex":0.005944503,"about_ca_topic_score_gemma":0.00999409,"teacher_disagreement_score":0.005944503,"about_ca_system_score_codex":0.002818884,"about_ca_system_score_gemma":0.006908786,"threshold_uncertainty_score":0.0204525},"labels":[],"label_agreement":null},{"id":"W4313463763","doi":"10.22270/ijdra.v10i4.545","title":"Regulatory Prospective on Software as a Medical Device","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical device; Business; Software; Quality (philosophy); Process (computing); Nuclear decommissioning; Risk analysis (engineering); Engineering management; Medicine; Computer science; Engineering","score_opus":0.004316054514093103,"score_gpt":0.2227435232564608,"score_spread":0.21842746874236768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313463763","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009949356,0.032190062,0.017110825,0.27371952,0.012732782,0.00047929215,0.0008617482,0.0006902596,0.65226614],"genre_scores_gemma":[0.21848838,0.05035926,0.03328013,0.44065592,0.010823074,0.0014055305,0.0017198565,0.00068341,0.24258433],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.947272,0.013358286,0.0039904728,0.0038127739,0.029076694,0.0024897773],"domain_scores_gemma":[0.9035348,0.043943796,0.0062402366,0.006879533,0.036053732,0.0033478898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029352551,0.00076202775,0.00070680055,0.0028847628,0.004779242,0.012212739,0.0027010543,0.016911386,0.012067807],"category_scores_gemma":[0.06450634,0.0006901878,0.0015218215,0.0022900312,0.00871734,0.006940058,0.004874298,0.016529758,0.0047584483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009733352,0.00013090365,0.0015025326,0.000756819,0.000022225102,0.0005289392,0.0021159765,0.00044931428,0.0032558746,0.68517977,0.21934628,0.086613975],"study_design_scores_gemma":[0.000013402189,0.00007868623,0.00090415194,0.0013828439,0.000019588308,0.00039970723,0.00033955384,0.00019082763,0.001139768,0.017634153,0.97785884,0.000038435453],"about_ca_topic_score_codex":0.00796623,"about_ca_topic_score_gemma":0.0054877987,"teacher_disagreement_score":0.029352551,"about_ca_system_score_codex":0.004135786,"about_ca_system_score_gemma":0.023397619,"threshold_uncertainty_score":0.15523297},"labels":[],"label_agreement":null},{"id":"W4313464260","doi":"10.22270/ijdra.v10i2.518","title":"A Comparative Study of Biologic Regulation in US, Canada, Australia, Europe and Singapore","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regulatory science; Product (mathematics); Regulatory authority; Order (exchange); Business; Quality (philosophy); Control (management); New product development; Developed country; International trade; Political science; Public administration; Marketing; Medicine; Economics; Environmental health; Management; Finance","score_opus":0.030783674348117927,"score_gpt":0.30298779999825287,"score_spread":0.27220412565013496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313464260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8545343,0.007681444,0.0005448775,0.0023248326,0.00007896406,0.00008217018,0.0023092467,0.00006613147,0.132378],"genre_scores_gemma":[0.98657227,0.0022368943,0.0002719206,0.0004535032,0.000016378277,0.000018088189,0.0009841396,0.000018460858,0.009428277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960354,0.0004596642,0.00027903586,0.00022286025,0.0021034058,0.00089969224],"domain_scores_gemma":[0.99120295,0.0012658497,0.0019112084,0.00020460565,0.004519143,0.0008962344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022874093,0.000153975,0.00026054712,0.004386587,0.0015719801,0.0023475585,0.0005754774,0.0003105273,0.0035230033],"category_scores_gemma":[0.006559885,0.00013256933,0.00048004615,0.00964011,0.0012541543,0.0007046964,0.0009597953,0.0005997519,0.00034858732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006970747,0.00013197592,0.8097125,0.0004963402,0.0002792473,0.001338379,0.014696085,0.0010879678,0.0014642568,0.050932225,0.013897145,0.105266884],"study_design_scores_gemma":[0.0000059707436,0.00007094218,0.96417725,0.00007841246,0.00004722605,0.00019394023,0.007420149,0.00030812089,0.00032019094,0.00022648452,0.027129738,0.000021623126],"about_ca_topic_score_codex":0.8721673,"about_ca_topic_score_gemma":0.92481476,"teacher_disagreement_score":0.12783271,"about_ca_system_score_codex":0.020954732,"about_ca_system_score_gemma":0.023329189,"threshold_uncertainty_score":0.25717103},"labels":[],"label_agreement":null},{"id":"W4313464290","doi":"10.22270/ijdra.v10i2.522","title":"Analysis on the registration and review system of emergency medical devices in China and abroad in the context of COVID-19","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Disaster Response and Management","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"China; Context (archaeology); Medical emergency; Quality (philosophy); European union; Coronavirus disease 2019 (COVID-19); Emergency management; Medicine; Business; Political science; Law; Geography; Infectious disease (medical specialty)","score_opus":0.031174747960885315,"score_gpt":0.4000642910526693,"score_spread":0.36888954309178396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313464290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85174495,0.031225894,0.009765293,0.024924098,0.00078004535,0.0018358874,0.0034764078,0.00025069935,0.07599676],"genre_scores_gemma":[0.9759748,0.008546262,0.0048094504,0.001639866,0.00021152322,0.0003990058,0.0011617612,0.00003884214,0.0072184773],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9700394,0.009293104,0.005881866,0.0027596122,0.009556466,0.002469559],"domain_scores_gemma":[0.9466912,0.016704882,0.011388593,0.0016590316,0.020973654,0.0025826383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025697658,0.00022639961,0.00043069397,0.009124603,0.0019964334,0.0043087676,0.0011578491,0.0008564207,0.0049699033],"category_scores_gemma":[0.044893764,0.00034111436,0.0008206098,0.0087910965,0.0013411128,0.003976315,0.0019246653,0.00078812015,0.00045486624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005666092,0.0002879234,0.5117717,0.010140205,0.00044110403,0.0034229173,0.035875555,0.0024418647,0.0034170693,0.091509335,0.038420465,0.30170527],"study_design_scores_gemma":[0.00010976994,0.00042928557,0.8118792,0.0026783426,0.0008128277,0.0018148049,0.037925065,0.005670271,0.0035046963,0.0040266723,0.13089201,0.00025710554],"about_ca_topic_score_codex":0.03217311,"about_ca_topic_score_gemma":0.032252073,"teacher_disagreement_score":0.03217311,"about_ca_system_score_codex":0.010773931,"about_ca_system_score_gemma":0.024037518,"threshold_uncertainty_score":0.13590384},"labels":[],"label_agreement":null},{"id":"W4313464329","doi":"10.22270/ijdra.v10i2.514","title":"A Comparison of the Drug Approval Process in the United States and Canada","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug approval; Approved drug; Food and drug administration; Population; Clinical trial; Drug; Business; Family medicine; Pharmacology; Environmental health","score_opus":0.02606590921075354,"score_gpt":0.28600587898892915,"score_spread":0.25993996977817563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313464329","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19558671,0.32122198,0.0021790084,0.047690663,0.002012839,0.0015453163,0.02746015,0.0003054024,0.40199795],"genre_scores_gemma":[0.8350562,0.12774244,0.0035295044,0.010005246,0.00035581703,0.00048399006,0.008328283,0.00021542613,0.014283122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9624396,0.005022245,0.0041889097,0.0016624372,0.02281153,0.0038753387],"domain_scores_gemma":[0.85545814,0.031131186,0.014980967,0.0014989427,0.08895834,0.007972444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013243526,0.00032766862,0.0009621741,0.012468386,0.003644847,0.0090492545,0.0013823102,0.0009899056,0.009298049],"category_scores_gemma":[0.07807315,0.0003763375,0.0018285408,0.027551549,0.0023069046,0.0023589996,0.0017999876,0.0016158004,0.0007099349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044915467,0.0004514102,0.20988825,0.034001343,0.0021693185,0.0021718605,0.018168502,0.002232568,0.0015404703,0.083320916,0.182014,0.45954973],"study_design_scores_gemma":[0.00052815827,0.00036805045,0.5582224,0.019189585,0.0016908223,0.0012239937,0.020850424,0.00094174646,0.0010219378,0.0026139624,0.39299247,0.00035649395],"about_ca_topic_score_codex":0.95655775,"about_ca_topic_score_gemma":0.9722926,"teacher_disagreement_score":0.084635094,"about_ca_system_score_codex":0.084635094,"about_ca_system_score_gemma":0.18699302,"threshold_uncertainty_score":0.61407346},"labels":[],"label_agreement":null},{"id":"W4386997085","doi":"10.22270/ijdra.v11i3.619","title":"Comparative study of Regulatory requirement for preparation of Dossier for Registration of Veterinary Drug in US, EU and Canada","year":2023,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Timeline; Veterinary drug; Eu countries; Political science; Veterinary medicine; Drug approval; Veterinary Drugs; European union; Regulatory affairs; Medicine; Business; Public administration; Drug; Geography; Pharmacology; International trade","score_opus":0.11808932590784996,"score_gpt":0.4127227219144452,"score_spread":0.2946333960065952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386997085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6938875,0.0092119705,0.001430657,0.0057910145,0.00026300573,0.00035434772,0.0037893276,0.00012376817,0.28514835],"genre_scores_gemma":[0.9722322,0.0027226969,0.0007265357,0.001169378,0.000025697294,0.00003761222,0.0016042326,0.000045893903,0.021435807],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.985989,0.0012284182,0.0004825709,0.0007534582,0.009732302,0.0018141363],"domain_scores_gemma":[0.96532196,0.006585089,0.0031336886,0.00075215875,0.022396242,0.001810934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050054635,0.00018873518,0.00027039897,0.00279118,0.0021857666,0.004038981,0.0013868125,0.00080938946,0.0058320537],"category_scores_gemma":[0.025840597,0.0002026302,0.0006319896,0.0030458071,0.0013410745,0.0008592772,0.00083215395,0.0012854481,0.00045425247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003611429,0.0009143208,0.5025707,0.0024207034,0.00080537924,0.003267959,0.012078137,0.008454021,0.009002272,0.14808871,0.104918964,0.20386758],"study_design_scores_gemma":[0.00008194801,0.00036811095,0.84374547,0.00053373585,0.000331829,0.00074179133,0.014749102,0.0027102889,0.0037257997,0.0011538346,0.13168815,0.00016990778],"about_ca_topic_score_codex":0.9301094,"about_ca_topic_score_gemma":0.9552899,"teacher_disagreement_score":0.06989062,"about_ca_system_score_codex":0.027239839,"about_ca_system_score_gemma":0.043109857,"threshold_uncertainty_score":0.19763976},"labels":[],"label_agreement":null},{"id":"W4386997187","doi":"10.22270/ijdra.v11i3.613","title":"Similarities and differences in filing for Drug Master File in US, Canada and Europe","year":2023,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Sleep Medicine Foundation","keywords":"Discretion; Confidentiality; Business; Database; Computer science; Law; Computer security; Political science","score_opus":0.037005608732142564,"score_gpt":0.24562269380943796,"score_spread":0.2086170850772954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386997187","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20886211,0.015292943,0.005633248,0.02558064,0.0020724903,0.0014207884,0.043512445,0.0014419483,0.69618344],"genre_scores_gemma":[0.75931215,0.01527273,0.00963596,0.008831093,0.00028843427,0.00056367606,0.036803953,0.0016697482,0.16762216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97575015,0.0012960025,0.0016394097,0.0015050627,0.013545106,0.0062643075],"domain_scores_gemma":[0.93074733,0.006815872,0.0031265821,0.0021474436,0.050959025,0.00620375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009760354,0.00044985264,0.0008973309,0.015628397,0.00639365,0.010542373,0.0030148216,0.0012365445,0.023221571],"category_scores_gemma":[0.059387185,0.0005578841,0.0011091491,0.019683009,0.0022359479,0.0023785715,0.0023436218,0.002511774,0.0035049936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088721514,0.00027384277,0.12188656,0.0009990755,0.00024182737,0.0011302595,0.01149159,0.0026267115,0.0015903955,0.26268244,0.3689482,0.22724192],"study_design_scores_gemma":[0.00006791773,0.00008022141,0.5169398,0.0011785517,0.00007574818,0.0004409023,0.011284559,0.0008513147,0.0010785679,0.0025120382,0.46529016,0.0002002763],"about_ca_topic_score_codex":0.9689812,"about_ca_topic_score_gemma":0.970901,"teacher_disagreement_score":0.06776715,"about_ca_system_score_codex":0.06776715,"about_ca_system_score_gemma":0.10955436,"threshold_uncertainty_score":0.49168742},"labels":[],"label_agreement":null},{"id":"W4390571917","doi":"10.22270/ijdra.v11i4.633","title":"A Review on Next Generation eCTD – eCTD v4.0","year":2023,"lang":"en","type":"review","venue":"International Journal of Drug Regulatory Affairs","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Certification; XML; Process (computing); Business; Regulatory authority; Computer science; Information exchange; Product (mathematics); Accounting; World Wide Web; Political science; Telecommunications; Public administration; Law","score_opus":0.3663792009933086,"score_gpt":0.5315893539655137,"score_spread":0.16521015297220504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390571917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012634798,0.9931062,0.00029169364,0.0014846518,0.0007165784,0.000060017144,0.00017553092,0.000031188996,0.0040078377],"genre_scores_gemma":[0.0006922468,0.99458647,0.0006220458,0.0019611947,0.000186038,0.000054959437,0.0002531157,0.000007791272,0.001636084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913496,0.00018654727,0.00016826001,0.000085872605,0.00035357333,0.00007076951],"domain_scores_gemma":[0.9981604,0.000751857,0.00024948022,0.000055234465,0.0006607545,0.00012224187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026295686,0.00065986236,0.0013377488,0.003168371,0.00035290074,0.0013317125,0.0015483644,0.0013799927,0.011899275],"category_scores_gemma":[0.004067224,0.00034976206,0.0016759185,0.0028966528,0.00037833137,0.0017020985,0.0009563732,0.0018113969,0.0043991352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000899781,0.000060609254,0.00013284605,0.054139312,0.00018318022,0.00013792071,0.00008161166,0.0001799211,0.0011195592,0.0050923857,0.09803145,0.84075123],"study_design_scores_gemma":[0.000021495724,0.00006908846,0.00031713693,0.0112923,0.00020832174,0.00027462174,0.000020951247,0.0000230758,0.0002202489,0.0005846981,0.98695785,0.000010343242],"about_ca_topic_score_codex":0.0022376582,"about_ca_topic_score_gemma":0.005545692,"teacher_disagreement_score":0.011899275,"about_ca_system_score_codex":0.0013032599,"about_ca_system_score_gemma":0.0047582495,"threshold_uncertainty_score":0.03980702},"labels":[],"label_agreement":null},{"id":"W4390572338","doi":"10.22270/ijdra.v11i4.631","title":"A Review on Approval and Registration Process of Medical Devices in Canada and India","year":2023,"lang":"en","type":"review","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; Canadian Institutes of Health Research","funders":"","keywords":"Business; Health technology; Population; Medicine; Health care; Order (exchange); Marketing; Medical emergency; Finance; Environmental health; Economic growth","score_opus":0.05931262392609347,"score_gpt":0.34678687639898353,"score_spread":0.28747425247289005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390572338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026089328,0.99349904,0.00009242288,0.0008632157,0.00022935434,0.000035812343,0.00012356677,0.0000075890134,0.0048880954],"genre_scores_gemma":[0.0032214848,0.99488646,0.00022150582,0.00050616823,0.00008741809,0.000021242595,0.00008863727,0.0000036361034,0.0009634114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965485,0.00055449764,0.0005808545,0.00023581606,0.0018433165,0.00023720997],"domain_scores_gemma":[0.9871563,0.0069551617,0.0015236062,0.00020859267,0.0038153508,0.00034100516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004258789,0.0007323198,0.0014048797,0.0077402024,0.0012787532,0.0029788977,0.0016472184,0.0017530125,0.0077755013],"category_scores_gemma":[0.011677173,0.0004907982,0.00139316,0.010756113,0.0015176025,0.0015121166,0.0007790152,0.0017286309,0.0010752185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013796422,0.00008878193,0.00081686385,0.083206564,0.0001788909,0.000442178,0.00035998147,0.00054680585,0.00046476503,0.01716252,0.07921793,0.8173768],"study_design_scores_gemma":[0.00003135358,0.000082909224,0.004816094,0.029594848,0.000299058,0.00074012415,0.00016771683,0.00010664381,0.00042563165,0.0006685136,0.9630251,0.00004201547],"about_ca_topic_score_codex":0.13160436,"about_ca_topic_score_gemma":0.1884207,"teacher_disagreement_score":0.9885019,"about_ca_system_score_codex":0.011498108,"about_ca_system_score_gemma":0.03397614,"threshold_uncertainty_score":0.26167673},"labels":[],"label_agreement":null},{"id":"W4393390818","doi":"10.22270/ijdra.v12i1.654","title":"Overview of Post-approval Submissions Management in US, Europe and Canada","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science; Library science; Geography; Computer science","score_opus":0.11527210434906467,"score_gpt":0.37307770650916056,"score_spread":0.2578056021600959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393390818","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06256391,0.10474579,0.016626317,0.056939915,0.0028239465,0.0024541928,0.022049569,0.004075836,0.72772056],"genre_scores_gemma":[0.41993877,0.18850288,0.052269567,0.028495004,0.0008245994,0.00075392675,0.023189196,0.0015910843,0.28443494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848897,0.0007537455,0.0008423025,0.00094650977,0.009343753,0.0032239216],"domain_scores_gemma":[0.96118265,0.0019467286,0.0018803279,0.0005286206,0.028548477,0.005913327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009433103,0.0008025086,0.00048913347,0.012319437,0.0070785494,0.009668623,0.0036787307,0.0017399953,0.013549091],"category_scores_gemma":[0.012351074,0.00074084057,0.0010671081,0.01728913,0.0026415875,0.0022803196,0.0023141638,0.001953918,0.002885789],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002638742,0.00026204903,0.049860734,0.0018944202,0.000071133836,0.0009394195,0.0024683054,0.0028864485,0.0019690525,0.067494065,0.28823027,0.58366036],"study_design_scores_gemma":[0.000019622288,0.00005914234,0.07256619,0.0010443854,0.000043152468,0.00033497618,0.0020571065,0.001060281,0.0012856247,0.0011558718,0.9202377,0.00013592605],"about_ca_topic_score_codex":0.9749537,"about_ca_topic_score_gemma":0.97821623,"teacher_disagreement_score":0.11584891,"about_ca_system_score_codex":0.11584891,"about_ca_system_score_gemma":0.2563968,"threshold_uncertainty_score":0.8405466},"labels":[],"label_agreement":null},{"id":"W4393393898","doi":"10.22270/ijdra.v12i1.624","title":"Nitrosamine Contamination in Pharmaceuticals: Regulatory Perspectives and Control Strategies of USFDA, EMA & HC","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Chemical Analysis and Environmental Impact","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Contamination; Business; Chemistry; Biotechnology; Biology; Ecology","score_opus":0.007917743006577903,"score_gpt":0.27616596459668186,"score_spread":0.268248221590104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393393898","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03994042,0.24848077,0.024325622,0.41143477,0.0036400827,0.00073345925,0.0019096595,0.00061975984,0.26891544],"genre_scores_gemma":[0.4023638,0.29399604,0.08961341,0.1035504,0.0022427894,0.00070143206,0.0021762047,0.00016491344,0.10519104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923693,0.0013582296,0.00044806494,0.000602753,0.0046439157,0.0005775592],"domain_scores_gemma":[0.98860776,0.0017507502,0.0012799579,0.0002993664,0.0075530885,0.00050900155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009468145,0.00063731545,0.0002709962,0.0023688192,0.0018420191,0.005553437,0.0018297902,0.005174848,0.00595847],"category_scores_gemma":[0.006703981,0.00023957604,0.0006068904,0.0015768666,0.0023147461,0.0025733171,0.001543118,0.002547984,0.0008798732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015673475,0.00038354177,0.015313882,0.0025431137,0.00006833007,0.0019890098,0.0015133334,0.0019416839,0.016329141,0.07311585,0.17217241,0.714473],"study_design_scores_gemma":[0.000019883531,0.0002541868,0.01298733,0.0030073298,0.00004798065,0.0011158948,0.0025220448,0.0014019741,0.015136876,0.0116512235,0.9517746,0.0000808101],"about_ca_topic_score_codex":0.07645536,"about_ca_topic_score_gemma":0.06717719,"teacher_disagreement_score":0.92354465,"about_ca_system_score_codex":0.00938721,"about_ca_system_score_gemma":0.024384921,"threshold_uncertainty_score":0.1520207},"labels":[],"label_agreement":null},{"id":"W4403169632","doi":"10.22270/ijdra.v12i3.699","title":"Index of application status transparency and availability of public information for Project Orbis agencies","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Geographic Information Systems Studies","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of Canada","funders":"Health Canada; U.S. Food and Drug Administration","keywords":"Transparency (behavior); Index (typography); Business; Public administration; Political science; Computer science; Computer security; World Wide Web","score_opus":0.02176827848225863,"score_gpt":0.307281380863256,"score_spread":0.28551310238099736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403169632","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02905708,0.0060486826,0.01506638,0.04964346,0.0029715116,0.0025775784,0.06496159,0.004104039,0.8255696],"genre_scores_gemma":[0.5403883,0.009509082,0.034089975,0.02205747,0.005149263,0.011550792,0.084391594,0.0047114175,0.28815216],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.79834974,0.04052428,0.026538663,0.009725477,0.11303948,0.011822366],"domain_scores_gemma":[0.52342254,0.14590225,0.090315945,0.055068452,0.16672595,0.018564925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.097002216,0.0009989666,0.0012958748,0.025743106,0.0048597716,0.029216286,0.0040809605,0.0054711606,0.08309607],"category_scores_gemma":[0.38985875,0.0010263231,0.0016278776,0.023177447,0.0036161372,0.017415177,0.0112124635,0.0054558865,0.025950897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000752076,0.00021153217,0.040565383,0.0033787794,0.0001653873,0.0004755926,0.0032466515,0.000822163,0.0009218363,0.15707058,0.5458298,0.24656028],"study_design_scores_gemma":[0.00007297815,0.00010085489,0.03984216,0.0018594192,0.00006445037,0.00038443608,0.0014714899,0.00090183364,0.0009899114,0.012697308,0.9415004,0.00011473425],"about_ca_topic_score_codex":0.014353549,"about_ca_topic_score_gemma":0.0043566967,"teacher_disagreement_score":0.097002216,"about_ca_system_score_codex":0.0125377625,"about_ca_system_score_gemma":0.037417,"threshold_uncertainty_score":0.5130029},"labels":[],"label_agreement":null},{"id":"W4403169648","doi":"10.22270/ijdra.v12i3.680","title":"Post-approval changes in Labelling regulations in the United States, European Union and Canada","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"European union; Labelling; International trade; Political science; Business; Psychology; Criminology","score_opus":0.01149745353016584,"score_gpt":0.25296381770849513,"score_spread":0.24146636417832928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403169648","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08725261,0.09997096,0.010997105,0.076590665,0.0065072794,0.0008673899,0.0030201445,0.0007119729,0.714082],"genre_scores_gemma":[0.7153131,0.06293735,0.018625323,0.087729976,0.000900511,0.00031721045,0.0032966097,0.00042716973,0.110452816],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.91105944,0.0070568114,0.004773771,0.004046674,0.06418937,0.008873812],"domain_scores_gemma":[0.8769573,0.021311898,0.0059549287,0.0038370509,0.08907123,0.0028676135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03532306,0.0003923134,0.0007243117,0.004652071,0.008079215,0.01199073,0.0038931873,0.0059627444,0.0037255846],"category_scores_gemma":[0.05250853,0.0006806695,0.0014441183,0.0071174144,0.00814344,0.0029711626,0.0023919141,0.0054169637,0.000566779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030505063,0.00021938345,0.022065101,0.0020289721,0.00017994795,0.0014433688,0.013713645,0.0026369747,0.0037270067,0.45970592,0.18442549,0.3095491],"study_design_scores_gemma":[0.000036104215,0.00009464822,0.06282296,0.0023280706,0.00012982557,0.00033437577,0.0035899924,0.0006377856,0.0037821503,0.006474608,0.9194958,0.0002736343],"about_ca_topic_score_codex":0.93627256,"about_ca_topic_score_gemma":0.95602447,"teacher_disagreement_score":0.08662954,"about_ca_system_score_codex":0.08662954,"about_ca_system_score_gemma":0.18136242,"threshold_uncertainty_score":0.6285442},"labels":[],"label_agreement":null},{"id":"W4405847843","doi":"10.22270/ijdra.v12i4.724","title":"Comparison of GMP for Drugs in EU, US, Canada, WHO and Australia","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Good manufacturing practice; Business; European union; Sanitation; Quality (philosophy); Product (mathematics); Production (economics); International trade; Marketing; Medicine; Economics","score_opus":0.047135678910785586,"score_gpt":0.40881887362515945,"score_spread":0.3616831947143739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405847843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8758275,0.007920247,0.00091368286,0.0028406645,0.00006271427,0.00013132073,0.0019407659,0.000044576038,0.110318504],"genre_scores_gemma":[0.9908574,0.0024443734,0.0007733598,0.0005590727,0.000011122083,0.000025359375,0.0008499635,0.000022049338,0.004457221],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958883,0.0007397023,0.00033492898,0.0002720267,0.0019896708,0.00077550893],"domain_scores_gemma":[0.9918075,0.001596517,0.0015733243,0.0002608025,0.0041245953,0.0006372772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003163321,0.00014398557,0.0002750737,0.002266277,0.00091022777,0.001784472,0.00045268788,0.0002782349,0.0018032693],"category_scores_gemma":[0.011424406,0.000119949895,0.0003646509,0.004484204,0.00092379254,0.0008104923,0.0010749594,0.00057881454,0.00014201469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001191149,0.00023540448,0.6594183,0.0012686113,0.0005803818,0.0012751188,0.028345196,0.0023019873,0.0030338024,0.058867265,0.015645698,0.22783706],"study_design_scores_gemma":[0.000012299444,0.00009791707,0.95372856,0.00021696647,0.00009432601,0.00024900463,0.013014115,0.0005913936,0.0007428296,0.00058979116,0.030637568,0.000025196156],"about_ca_topic_score_codex":0.6270097,"about_ca_topic_score_gemma":0.7218545,"teacher_disagreement_score":0.3729903,"about_ca_system_score_codex":0.008573873,"about_ca_system_score_gemma":0.011167226,"threshold_uncertainty_score":0.75037384},"labels":[],"label_agreement":null},{"id":"W4413299648","doi":"10.22270/ijdra.v13i1.735","title":"Comparative Study of Medical Device Regulation in US, EU and Canada","year":2025,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science; Business; International trade","score_opus":0.014259337278858364,"score_gpt":0.32805686753826435,"score_spread":0.313797530259406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413299648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5832392,0.017416282,0.0016821924,0.017692598,0.00020955468,0.00020701702,0.0038081198,0.0000695859,0.37567544],"genre_scores_gemma":[0.9789298,0.005194378,0.0007956019,0.004732258,0.000031439522,0.000045047662,0.0010301606,0.000047275775,0.009194154],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.98789215,0.0012154878,0.00054147403,0.000777885,0.0062984508,0.0032745188],"domain_scores_gemma":[0.97926027,0.0043887245,0.0023573737,0.0004890073,0.011374142,0.0021304877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045038303,0.00017416745,0.0004030681,0.0052201427,0.0042682122,0.0057729343,0.0010899159,0.0011491538,0.0044000605],"category_scores_gemma":[0.021424202,0.0002449707,0.0005760874,0.009788122,0.002668247,0.0009725851,0.0021833698,0.0014489968,0.00020697173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010095991,0.00020660818,0.36942753,0.0010418281,0.0004273365,0.0020939629,0.02196147,0.0026531888,0.001745088,0.39142457,0.049021475,0.15898734],"study_design_scores_gemma":[0.000069820875,0.0001080064,0.7277256,0.0010490636,0.00022259714,0.00094332383,0.028937338,0.0015519637,0.0013487822,0.0035936772,0.23428036,0.00016951942],"about_ca_topic_score_codex":0.96975,"about_ca_topic_score_gemma":0.9819556,"teacher_disagreement_score":0.06581221,"about_ca_system_score_codex":0.06581221,"about_ca_system_score_gemma":0.09003586,"threshold_uncertainty_score":0.47750324},"labels":[],"label_agreement":null}]}